ARISTEA THERAPEUTICS
Aristea Therapeutics is a developer of novel therapies created for autoimmune diseases.The company's therapies include developing drugs, enabling inflammatory diseases patients to address their unmet medical needs.
ARISTEA THERAPEUTICS
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2018-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.aristeatx.com
Total Employee:
1+
Status:
Active
Contact:
858-987-4064
Total Funding:
117.62 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Amazon SSL By Default Microsoft Exchange Online Office 365 Mail GoDaddy DNS AWS Global Accelerator
Similar Organizations
Alchemab Therapeutics
Alchemab Therapeutics is developing protective antibodies designed to keep people free of hard-to-treat diseases.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Engrail Therapeutics
Engrail Therapeutics is a developer of medicines to transform the lives of patients with life-limiting diseases of the nervous system.
Entrada Therapeutics
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
Kiniksa Pharmaceuticals
Kiniksa Pharmaceuticals is developing therapies for inflammatory and autoimmune conditions.
Memo Therapeutics
Memo Therapeutics is an innovator in the field of antibody discovery and immune repertoire analysis.
Skye Bioscience
Skye Bioscience is a biopharmaceutical company focused on the discovery, development, and the commercialization.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Sonoma BioTherapeutics
Sonoma BioTherapeutics develops adoptive Treg therapies cell for autoimmune.
Vico Therapeutics
Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies.
Current Advisors List
Board_member
Board_member
Current Employees Featured
James Mackay Founder,President and CEO @ Aristea Therapeutics
Founder,President and CEO
2018-01-01
Founder
Investors List
Arena Pharmaceuticals
Arena Pharmaceuticals investment in Series B - Aristea Therapeutics
Fidelity
Fidelity investment in Series B - Aristea Therapeutics
Novo Holdings
Novo Holdings investment in Series B - Aristea Therapeutics
Tekla Capital Management
Tekla Capital Management investment in Series B - Aristea Therapeutics
Novo Holdings
Novo Holdings investment in Series A - Aristea Therapeutics
Official Site Inspections
http://www.aristeatx.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 3.33.130.190
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Aristea Therapeutics"
Aristea Therapeutics - Crunchbase Company Profile
Contact Email info@aristeatx.com Phone Number 858-987-4064 Aristea Therapeutics is a developer of novel therapies created for autoimmune …See details»
Aristea Therapeutics, Inc. Company Profile | San Diego, CA ...
Find company research, competitor information, contact details & financial data for Aristea Therapeutics, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
Aristea Therapeutics 2025 Company Profile: Valuation, …
Aristea Therapeutics General Information Description. Operator of a drug development company intended to treat serious inflammatory diseases. The …See details»
Aristea Therapeutics Company Profile - Office Locations ... - Craft
Mar 28, 2022 Aristea Therapeutics has 5 employees at their 1 location and $78 m in total funding,. See insights on Aristea Therapeutics including office locations, competitors, revenue, …See details»
Aristea Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
View Aristea Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Aristea Therapeutics - 2025 Company Profile - Tracxn
Mar 10, 2025 Email ID: *****@aristeatx.com; Key Metrics. Total Funding. $118M in 3 rounds. Latest Funding Round. Series B, Jul 27, 2021, $63M. Investors. Fidelity Investments & 3 more. …See details»
Aristea Therapeutics - VentureRadar
Similar Companies: Immunic Therapeutics Germany Publicly Traded Immunic is a specialist in selective oral drugs in immunology and focused on developing novel oral therapies with best …See details»
Aristea Therapeutics Overview | SignalHire Company Profile
Aristea Therapeutics is a private company that has been in the industry for 5 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the President …See details»
Aristea Therapeutics Inc Overview - Salary.com
Discover essential details about Aristea Therapeutics Inc, including address, contact, and journey of our company's evolution.See details»
Aristea Therapeutics | LinkedIn
Aristea Therapeutics | 1,286 followers on LinkedIn. A clinical-stage drug development company developing novel therapies to treat serious inflammatory diseases. | Aristea Therapeutics (Air …See details»
Aristea Therapeutics, Inc. (Aristea Therapeutics, Inc.) - 药物管线_专 …
INTRODUCTION Palmoplantar pustulosis (PPP) is a chronic inflammatory skin condition with neutrophilic infiltration of the epidermis. RIST4721 antagonizes CXC chemokine receptor type …See details»
Aristea Therapeutics Announces Key Leadership Appointments
Jan 13, 2022 To learn more, please visit www.aristeatx.com and follow us on social media @Aristeatx. For media inquiries contact: David Schull or Ignacio Guerrero-Ros, Ph.D. Russo …See details»
Aristea Therapeutics - VentureRadar
Website: http://www.aristeatx.com/ Develops novel immunology-focused therapies for serious inflammatory diseases, currently conducting a Phase 2 clinical study for ...See details»
Aristea Therapeutics - Facebook
Aristea Therapeutics (Air-iss-tay-uh) is a clinical-stage drug development company developing novel therapies to treat serious inflammatory diseases, including palmoplantar pustulosis (PPP).See details»
Aristea Therapeutics Strengthens its Team with Appointments of ...
Nov 2, 2022 Aristea Therapeutics (Air-iss-tay-uh) is a clinical-stage immunology focused drug development company developing novel therapies to treat serious inflammatory diseases.See details»
Aristea Therapeutics Announces Key Leadership Appointments to …
Jan 13, 2022 To learn more, please visit www.aristeatx.com and follow us on social media @Aristeatx. For media inquiries contact: David Schull or Ignacio Guerrero-Ros, Ph.D. Russo …See details»
Aristea Therapeutics to Present at the 2nd Annual LifeSci Partners ...
Jul 16, 2021 To learn more, please visit www.aristeatx.com and follow us on social media @Aristeatx. For media inquiries contact: David Schull or Ignacio Guerrero-Ros Russo Partners …See details»
Aristea Therapeutics Closes $63M Series B Financing - FinSMEs
Jul 27, 2021 and follow us on social media @Aristeatx. For media inquiries contact: David Schull or Ignacio Guerrero-Ros, Ph.D. Russo Partners 858-717-2310 646-942-5604 [email protected],See details»
Arena Pharmaceuticals and Aristea Therapeutics Establish
Jul 27, 2021 PARK CITY, Utah, & SAN DIEGO--(BUSINESS WIRE)-- Arena Pharmaceuticals, Inc., (Nasdaq: ARNA) and Aristea Therapeutics, Inc. today announced a strategic …See details»
Aristea Completes $63 Million Series B Financing to Accelerate …
Jul 27, 2021 To learn more, please visit www.aristeatx.com and follow us on social media @Aristeatx. For media inquiries contact: David Schull or Ignacio Guerrero-Ros, Ph.D. Russo …See details»